Cerebras Tops Wall Street Estimates in Debut Earnings Report

Cerebras Systems designs and sells specialized AI chips that compete directly with the dominant players in the data center accelerator market. On Wednesday, June 18, the company reported its first quarterly earnings as a public company, beating Wall Street forecasts on both revenue and losses. Investors rewarded that with a selloff anyway.

At a Glance

• Cerebras Systems (NASDAQ: CBRS) closed at $188.56, down 17.12% on June 21, 2026
• 52-week range: $185.22 to $386.34, placing the stock near its one-year floor
• Market cap: $49.79 billion
• RSI: 34.13, approaching oversold territory
• The stock is roughly 4% above its IPO price of $185 and nearly 40% below its first-day closing price

A Beat That Did Not Feel Like One

Cerebras posted first-quarter revenue of $193.4 million, roughly $10 million above the analyst consensus tracked by Visible Alpha. The adjusted loss came in at $2.48 million, narrower than forecasters had expected. On paper, that is a clean beat for a young chipmaker in a crowded field.

The problem was guidance. Cerebras said it expects adjusted gross margins of 36% to 38% in the current quarter, a meaningful step down from the 47% it posted in Q1. For a company still proving its unit economics, that kind of compression gives investors pause. The stock, which had already been choppy since its debut, dropped sharply on the news.

Morgan Stanley pushed back on the gloom. Analysts there raised their price target to $273 from $250 after the report, telling clients that nothing in the numbers was actually disappointing. Their read: a freshly public company managing its first few quarters of public guidance may simply be setting a conservative bar. Demand for the company's chips, they noted, remains strong.

That argument has some merit. First time issuers routinely guide low to avoid the pain of a miss. Whether Cerebras is doing that deliberately or signaling genuine margin pressure is the question the market is trying to answer right now.

What the Numbers Say

At $188.56, Cerebras sits just above its 52-week low of $185.22 and a long way from its high of $386.34. The stock is down roughly 40% from its first-day close after going public last month, which means almost anyone who bought in the initial excitement is underwater.

No P/E ratio or EPS figure applies in the traditional sense here: Cerebras is not yet profitable on a GAAP basis, so those conventional valuation anchors are absent. The market cap of $49.79 billion is instead a bet on future revenue scale and margin expansion, which makes the gross margin guidance cut a particularly sensitive data point.

The RSI of 34.13 puts CBRS close to the threshold many technical traders associate with oversold conditions (typically below 30). That does not mean a floor has been found, but it does suggest the selling has been aggressive enough that some contrarian interest could emerge. No dividend is in place, so yield is not a factor in the valuation calculus.

Bull case: Strong chip demand, a beat on the first public report, a Morgan Stanley upgrade to $273, and an RSI near oversold levels all point to the possibility that the selloff has gone further than the fundamentals justify. The stock trading near its IPO price could attract buyers who see it as a reset opportunity.

Bear case: Margin compression from 47% to a guided 36% to 38% is not trivial. The company has no GAAP earnings to anchor a traditional valuation, and the 52-week high of $386.34 is a reminder of how far sentiment has already shifted. A continued pattern of margin pressure would make the $49.79 billion market cap harder to defend.

Frequently Asked Questions

Why did Cerebras stock drop after beating earnings estimates?

The quarterly revenue and loss figures both beat analyst expectations, but the company's guidance for current-quarter gross margins of 36% to 38% came in below the 47% it posted in Q1. That margin step-down appears to be driving the selling pressure more than the earnings beat itself.

How far is CBRS from its IPO price?

Cerebras priced its IPO at $185 per share. At $188.56, the stock is roughly 4% above that level. It is, however, down nearly 40% from the price at which it closed on its first day of trading.

What is Morgan Stanley's price target for CBRS?

Following the earnings report, Morgan Stanley raised its price target on Cerebras to $273 from $250, citing strong demand for the company's chips and noting that management may be guiding conservatively in its early quarters as a public company.

Does Cerebras pay a dividend?

No. Cerebras does not currently pay a dividend. The company is in a growth and investment phase, and no yield is factored into its current valuation.

Where Things Stand Now

Cerebras finds itself in the uncomfortable position many newly public tech companies know well: a solid first report overshadowed by a guidance number the market did not like. The IPO price at $185 has become a psychological reference point, and the stock is barely holding above it. Whether the margin compression is a temporary feature of scaling up or something more structural will likely define how CBRS trades over the next several quarters.